We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short course of corticosteroids with complete resolution of symptoms. To our knowledge this is the first reported case of TMP/SMX-induced DILE presenting with life-threatening serositis. When confronted with sterile exudative effusions, clinicians should strongly consider non-infectious etiologies.
VasooS. Drug-induced lupus: an update. Lupus2006; 15: 757–761.
2.
PetriMOrbaiAAlarconG. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64: 2677–2686.
3.
EpsteinABarlandP. The diagnostic value of anti-histone antibodies in drug-induced lupus erythematosus. Arthritis Rheum1985; 28: 158–162.
4.
CozzaniEDroseraMGaspariniGParodiA. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis2014; 2014: 321359–321359.
CohenMGProwseMV. Drug-induced rheumatic syndromes: diagnosis, clinical features and management. Med Toxicol Adverse Drug Exposure1989; 4: 199–218.
7.
ClementzGLDolinBJ. Sulfasalazine-induced lupus erythematosus. Am J Med1988; 84: 535–538.
8.
GuptaRHennebryTKinasewitzG. Pleuropericardial effusion after 37 years of sulfasalazine therapy. J Cardiovasc Med2012; 13: 541–543.
9.
PetriMAllbrittonJ. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol1992; 19: 265–269.
10.
Abu-HijlehMEvansSAswadB. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung2010; 168: 505–510.
